Merck & Co Inc logo

Merck & Co Inc

28
7
NYSE:MRK (USA)  
$ 102.55 -0.4 (-0.39%) 11:08 PM EST
On watch
P/E:
83.71
P/B:
6.70
Market Cap:
$ 260.22B
Enterprise V:
$ 291.77B
Volume:
7.01M
Avg Vol (2M):
6.49M
Also Trade In:
Volume:
7.01M
Market Cap $:
260.22B
PE Ratio:
83.71
Avg Vol (2M):
6.49M
Enterprise Value $:
291.77B
PB Ratio:
6.70

Business Description

Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Financials (Next Earnings Date:2023-10-27 Est.)

MRK's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:MRK

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Merck & Co Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 58,311
EPS (TTM) ($) 1.22
Beta 0.39
Volatility % 23.53
14-Day RSI 30.43
14-Day ATR ($) 1.651066
20-Day SMA ($) 106.6355
12-1 Month Momentum % 27.54
52-Week Range ($) 86.02 - 119.65
Shares Outstanding (Mil) 2,537.52

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merck & Co Inc Filings

Filing Date Document Date Form
No Filing Data

Merck & Co Inc Stock Events

Event Date Price($)
No Event Data

Merck & Co Inc Frequently Asked Questions

What is Merck & Co Inc(MRK)'s stock price today?
The current price of MRK is $102.55. The 52 week high of MRK is $119.65 and 52 week low is $86.02.
When is next earnings date of Merck & Co Inc(MRK)?
The next earnings date of Merck & Co Inc(MRK) is 2023-10-27 Est..
Does Merck & Co Inc(MRK) pay dividends? If so, how much?
The  Dividend Yield %  of Merck & Co Inc(MRK) is 2.84% (As of Today), Highest Dividend Payout Ratio of Merck & Co Inc(MRK) was 2.36. The lowest was 0.44. And the median was 1.09. The  Forward Dividend Yield % of Merck & Co Inc(MRK) is 2.84%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1